Treatment for Multiple Myeloma – Part 2

Description:

Review newer drugs used to treat multiple myeloma in a relapse setting: selinexor, and venetoclax.

Module Objectives:

Learn about the uses of selinexor, and venetoclax in the context of relapsed myeloma.
Educate healthcare professionals about the potential side effects and considerations of selinexor and venetoclax.

Instructor:

Beth Faiman, PhD, RN, MSN, APRN-BC, AOCN®, FAAN

An overview of nursing considerations for myeloma patients with renal impairment, including the role of dose modifications

An exciting novel treatment for patients with myeloma

Using the patient’s own immune system to destroy myeloma cells.

Is treatment working? An overview of myeloma treatment history and management over the course of the disease.

An overview of myeloma treatments: Steroids, IMiDs, and PIs

Review newer drugs used to treat multiple myeloma in a relapse setting: selinexor, and venetoclax.

High-level overview of autologous stem cell transplant (ASCT) for treatment of multiple myeloma.